LAB. PFIZER, LDA. secures contract for Acquisition Of Lorlatinib Oral 25Mg Comp Rev, Under Cpa 2023/491, For Ulsasi, For The Year 2026

Portugal, July 30 -- Portugal based LAB. PFIZER, LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Lorlatinib Oral 25Mg Comp Rev, Under Cpa 2023/491, For Ulsasi, For The Year 2026 . The value of the contract is worth 14580 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....